The Journal of International Advanced Otology
A Novel Biomarker for Bell’s Palsy: The Pan-Immune- Inflammation Value
By Serkan Altıparmak and Ayhan Kars.
Abstract
Background
The pan-immune-inflammation value (PIV) is a recently described novel biomarker obtained from complete blood count parameters. Systemic biomarkers have been investigated in a number of studies aimed at confirming the role of the inflammatory process in the etiology of Bell’s palsy (BP) and elucidating the association with prognosis. This study investigated the relationship between PIV and BP.